Moreover, some researchers found that TREM2 is highly expressed in TAMs in non-small cell lung cancer and liver cancer patients (22, 23), suggesting that the high expression of TREM2 is associated with poor prognosis of tumor patients. This evidence concerns the gene TREM2 and non-small cell lung carcinoma.